Skip to main content
Top
Published in: Journal of Gastroenterology 6/2007

01-06-2007 | Case Report

Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-α combination therapy following hepatic resection

Authors: Hiroshi Wada, Hiroaki Nagano, Takehiro Noda, Bazarragchaa Damdinsuren, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Keizo Dono, Masato Sakon, Kenichi Wakasa, Morito Monden

Published in: Journal of Gastroenterology | Issue 6/2007

Login to get access
Metadata
Title
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-α combination therapy following hepatic resection
Authors
Hiroshi Wada
Hiroaki Nagano
Takehiro Noda
Bazarragchaa Damdinsuren
Shigeru Marubashi
Atsushi Miyamoto
Yutaka Takeda
Koji Umeshita
Keizo Dono
Masato Sakon
Kenichi Wakasa
Morito Monden
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 6/2007
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-007-2028-x

Other articles of this Issue 6/2007

Journal of Gastroenterology 6/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine